1. Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands

   • Filippo Egalini
   • Lorenzo Marinelli
   • Roberta Giordano

   Review Open access 23 May 2022 Pages: 395 - 405

2. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management

   • Philippe Caron

   Review 28 June 2022 Pages: 406 - 417

3. The association between Takotsubo cardiomyopathy and thyrotoxicosis: A systematic review

   • Abdullahi Ahmed Mohamed
   • Tayfun Basaran
   • Steen Joop Bonnema

   Review 26 August 2022 Pages: 418 - 428

   

4. Environmental disruptors and testicular cancer

   • Fabiana Faja
   • Sandro Esteves
   • Donatella Paoli

   Mini Review Open access 29 August 2022 Pages: 429 - 435

   

5. Thyroid function changes and COVID-19 severity: egg or chicken?

   • Wenjie Chen
   • Jianyong Lei
   • Zhihui Li

   Viewpoint 25 July 2022 Pages: 436 - 440

   

6. Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question

   • Irene Caramella
   • Alberto Dalla Volta
   • Alfredo Berruti

   Viewpoint Open access 20 August 2022 Pages: 441 - 445

7. Sorafenib decreases glycemia by impairing hepatic glucose metabolism

   • Jingjing Ma
   • Fang Sui
   • Peng Hou

   Original Article 07 October 2022 Pages: 446 - 457

   

8. Predicting risk of obesity and meal planning to reduce the obese in adulthood using artificial intelligence

   • Rajdeep Kaur
   • Rakesh Kumar
   • Meenu Gupta

   Original Article 12 October 2022 Pages: 458 - 469

   

9. Accuracy of the intermittently scanned continuous glucose monitoring system in critically ill patients: a prospective, multicenter, observational study

   • Weifeng Huang
   • Siwan Li
   • Yingchuan Li

   Original Article 13 October 2022 Pages: 470 - 475

   

10. Hypothalamic insulin expression remains unaltered after short-term fasting in female rats

    • Tamara B. Dakic
    • Milica B. Markelic
    • Predrag Z. Vujovic

    Original Article 27 October 2022 Pages: 476 - 483

    

11. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes

    • Ziyu Luo
    • Hu Hei
    • Wenbo Gong

    Original Article 26 August 2022 Pages: 484 - 490

    

12. Identification of the collagen family as prognostic biomarkers in papillary thyroid carcinoma

    • Juntao Niu
    • Wenyu Guo
    • Ning Jiang

    Original Article 07 September 2022 Pages: 491 - 506

    

13. The combination of BRAF^V600E mutation and Chinese Thyroid Imaging Reporting and Data System is helpful in the management of AUS/FLUS thyroid nodules

    • Qiang Li
    • Lu Yang
    • Shiyan Li

    Original Article 24 September 2022 Pages: 507 - 516

    

14. Integrated analysis of novel macrophage related signature in anaplastic thyroid cancer

    • Yi Luo
    • Yi-Chen Yang
    • Yu Wang

    Original Article 07 September 2022 Pages: 517 - 530

    

15. Incomplete response to therapy in intermediate- and high-risk thyroid cancer

    • Ali S. Alzahrani
    • Noha Mukhtar

    Original Article 08 September 2022 Pages: 531 - 542

    

16. Prognostic significance of lung metastasis-related finding in lenvatinib treatment for differentiated thyroid cancer

    • Haruhiko Yamazaki
    • Hiroyuki Iwasaki
    • Yasushi Rino

    Original Article 07 September 2022 Pages: 543 - 551

    

17. Pregnancy after pituitary surgery does not influence the recurrence of Cushing’s disease

    • Lia Mesquita Lousada
    • Mariuxi Jacqueline Borja Tapia
    • Marcio Carlos Machado

    Original Article 05 August 2022 Pages: 552 - 558

    

18. Effect of pituitary adenoma consistency on surgical outcomes in patients undergoing endonasal endoscopic transsphenoidal surgery

    • A. Acitores Cancela
    • V. Rodríguez Berrocal
    • P. Iglesias

    Original Article 13 August 2022 Pages: 559 - 569

    

19. Pre- and peri-operative characteristics, complications and outcomes of patients with biochemically silent pheochromocytomas; a case series

    • Athanasios Fountas
    • Georgia Kanti
    • Labrini Papanastasiou

    Original Article 08 September 2022 Pages: 570 - 579

20. Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease

    • Mojca Jensterle
    • Ana Podbregar
    • Katja Prokšelj

    Original Article 04 October 2022 Pages: 580 - 586

    

21. Dietary inflammatory index and osteoporosis: the National Health and Nutrition Examination Survey, 2017–2018

    • Saisai Zhao
    • Wenhui Gao
    • Lina Jin

    Original Article 31 August 2022 Pages: 587 - 596

    

22. Cortex or cancellous—which is early for the decrease of bone content for vertebral body in health?

    • Lin Bai
    • Jujia Li
    • Ping Zhang

    Original Article 22 September 2022 Pages: 597 - 604

    

23. Full-length versus intact PTH concentrations in pseudohypoparathyroidism type 1 and primary hyperparathyroidism: clinical evaluation of immunoassays in individuals from China

    • Yi Yang
    • Ailing Song
    • Ou Wang

    Original Article 11 October 2022 Pages: 605 - 614

    

24. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome

    • Gan Qiao
    • Jinshan Xing
    • Jingyan Yi

    Original Article 06 September 2022 Pages: 615 - 627

    

25. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity

    • Kehinde S. Olaniyi
    • Stephanie E. Areloegbe
    • Mosunmola B. Oyeleke

    Original Article 16 September 2022 Pages: 628 - 640

    

26. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination

    • Rujittika Mungmunpuntipantip
    • Viroj Wiwanitkit

    Letter to the Editor 19 August 2022 Pages: 641 - 641

27. Accuracy in the diagnosis of hypertension and CKD is key to determine their possible association

    • Miguel Angel Maria Tablado

    Letter to the Editor 23 July 2022 Pages: 642 - 643